Παρασκευή 2 Μαρτίου 2018

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells, Published online: 02 March 2018; doi:10.1038/s41416-018-0025-x

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells

http://ift.tt/2F617aN

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου